Heron Therapeutics (HRTX) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free HRTX Stock Alerts $2.45 -0.10 (-3.92%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHeron Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.09) Per Share, Capital One Financial Forecasts (NASDAQ:HRTX)americanbankingnews.com - April 26 at 1:36 AMHeron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlookfinance.yahoo.com - April 25 at 8:25 AMEquities Analysts Offer Predictions for Heron Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:HRTX)marketbeat.com - April 25 at 7:37 AMHeron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024prnewswire.com - April 24 at 8:00 AMHeron Therapeutics (NASDAQ:HRTX) Coverage Initiated by Analysts at Capital One Financialamericanbankingnews.com - April 24 at 4:44 AMCapital One Initiates Coverage of Heron Therapeutics (HRTX) with Overweight Recommendationmsn.com - April 23 at 9:28 PMHeron Therapeutics (NASDAQ:HRTX) Coverage Initiated at Capital One Financialmarketbeat.com - April 23 at 7:15 AMHeron Therapeutics: Zynrelef Potentially Eases Shareholder Painseekingalpha.com - April 16 at 6:27 PMCommit To Buy Heron Therapeutics At $2, Earn 22.4% Annualized Using Optionsnasdaq.com - April 12 at 12:35 AMHeron Therapeutics to Host Investor Day on May 15, 2024 in New York Cityprnewswire.com - April 11 at 4:05 PMCongress Park Capital LLC Purchases 1,209,500 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)marketbeat.com - April 1 at 6:28 AMHeron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conferenceprnewswire.com - March 28 at 4:05 PMHeron Therapeutics (NASDAQ:HRTX) Shares Pass Above Two Hundred Day Moving Average of $1.67marketbeat.com - March 21 at 3:11 AMHRTX Apr 2024 1.500 callca.finance.yahoo.com - March 16 at 4:59 AMHeron Therapeutics Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 14 at 9:02 AMHeron Therapeutics Soars After 4Q Earnings Beatmarketwatch.com - March 14 at 12:50 AMBiotech Finds Mid-Week Success Following Q4 Earnings Releasetheglobeandmail.com - March 13 at 7:49 PMWhy Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?markets.businessinsider.com - March 13 at 7:49 PMQ4 2023 Heron Therapeutics Inc Earnings Callfinance.yahoo.com - March 13 at 9:49 AMHeron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 13 at 9:49 AMHeron Therapeutics (NASDAQ:HRTX) Given New $5.00 Price Target at Needham & Company LLCmarketbeat.com - March 13 at 8:18 AMHeron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updatesfinance.yahoo.com - March 12 at 6:03 PMHeron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023finance.yahoo.com - March 12 at 6:03 PMHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by Adage Capital Partners GP L.L.C.marketbeat.com - March 12 at 5:53 AMHeron Therapeutics Q4 2023 Earnings Previewmsn.com - March 11 at 8:11 PMWhat Wall Street expects from Heron Therapeutics's earningsmarkets.businessinsider.com - March 11 at 3:10 PMPreview: Heron Therapeutics's Earningsbenzinga.com - March 11 at 3:10 PMHeron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesdaymarketbeat.com - March 5 at 4:50 AMHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024finance.yahoo.com - February 28 at 10:49 AMHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024prnewswire.com - February 28 at 8:00 AMHeron Therapeutics (HRTX) Price Target Increased by 18.52% to 6.80msn.com - February 24 at 9:19 AMHeron Therapeutics Stock (NASDAQ:HRTX), Short Interest Reportbenzinga.com - February 22 at 9:16 AMHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO.marketbeat.com - February 17 at 6:12 AMHRTX Mar 2024 0.500 callfinance.yahoo.com - February 17 at 1:37 AMTejara Capital Ltd Acquires 469,548 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)marketbeat.com - February 16 at 12:21 PMInvestors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23% gain this past weekfinance.yahoo.com - February 16 at 10:36 AMJW Asset Management LLC Increases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)marketbeat.com - February 12 at 12:53 PMOcular Therapeutix (OCUL) Surges 12.9%: Is This an Indication of Further Gains?finance.yahoo.com - February 12 at 8:20 AMAll You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buyfinance.yahoo.com - February 6 at 1:46 PMHeron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansionfinance.yahoo.com - January 25 at 8:39 AMHeron Therapeutics Shares Rise 15% After FDA Approves Expanded Use of Zynrelefmarketwatch.com - January 24 at 10:38 PMHeron Therapeutics: Strong Buy on Zynrelef’s Market Expansion and Strategic Collaborationsmarkets.businessinsider.com - January 24 at 10:38 PMPremarket Heats Up For Biotech Before Opening Bellmsn.com - January 24 at 5:34 PMHeron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nodfinance.yahoo.com - January 24 at 5:34 PMHeron Therapeutics rises on securing label expansion for pain therapymsn.com - January 24 at 7:44 AMHeron : FDA Oks ZYNRELEF Indication Expansion To Include Addl. Orthopedic & Soft Tissue Proceduresmarkets.businessinsider.com - January 24 at 2:43 AMHeron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Proceduresfinance.yahoo.com - January 23 at 9:42 PMHeron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the companyfinance.yahoo.com - January 22 at 9:57 AMHeron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?finance.yahoo.com - January 15 at 12:53 PMHeron Therapeutics Shares Rise 17% After Zynrelef Distribution Partnershipmarketwatch.com - January 9 at 6:38 PM Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. HRTX Media Mentions By Week HRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRTX News Sentiment▼0.710.33▲Average Medical News Sentiment HRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRTX Articles This Week▼112▲HRTX Articles Average Week Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Harrow Health News Today Biomea Fusion News Today Neurogene News Today Entrada Therapeutics News Today Mersana Therapeutics News Today Avid Bioservices News Today Fulcrum Therapeutics News Today Annexon News Today Larimar Therapeutics News Today Lexicon Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRTX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
